HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High α-defensin and S100A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation.

AbstractPURPOSE:
The purposes of this study were to analyze the gene expression pattern of antimicrobial peptides, tumor suppressors, growth factors, matrix metalloproteases, and inflammatory cytokines and chemokines in oral irritation fibromas and to identify genes with protective effects against malignant transformation in benign proliferating tumors of the oral mucosa.
MATERIALS AND METHODS:
Biopsies of irritation fibromas (n = 15) and healthy gingiva (n = 15) were obtained during routine surgical procedures. RNA was extracted according to standard protocols, and transcription levels of CCL20, DEFA 1/3, DEFA 4, S100A7, DOC-1, interleukin (IL) 1β, IL-6, IL-8, IL-10, tumor necrosis factor α, Cox-2, matrix metalloproteinase 1 (MMP-1), MMP-2, MMP-3, MMP-8, MMP-9, transforming growth factor β1, transforming growth factor α, and keratinocyte growth factor were analyzed by real-time polymerase chain reaction. In addition, immunostaining was performed to visualize the transcription products of the genes of interest in fibroma tissue as well as in healthy gingiva.
RESULTS:
The gene expression of S100A7 was 11.3-fold and that of DEFA 1/3 was 14-fold higher in irritation fibromas than in healthy gingiva, whereas the expression of MMP-3 and of inflammation markers IL-1β, IL-6, IL-8, tumor necrosis factor α, and Cox-2 was reduced. Profound down-regulation of DOC-1 gene expression, characteristic for proliferating malignant tumors of the oral cavity, was in irritation fibromas not verifiable.
CONCLUSIONS:
Changes in the expression pattern of S100A7, DEFA 1/3, and MMP-3 seem to be involved in the development of irritation fibromas, whereas chronic inflammation might be of less importance. Overexpression of S100A7, but missing down-regulation of the tumor-suppressor gene DOC-1, might exert protective effects and counteract malignant transformation of benign, proliferating lesions of the oral cavity.
AuthorsJochen Winter, Annette Pantelis, Jean-Pierre Allam, Natalija Novak, Rudolf Reich, Markus Martini, Stefaan Bergé, James Deschner, Soeren Jepsen, Matthias Wenghoefer
JournalThe Journal of craniofacial surgery (J Craniofac Surg) Vol. 22 Issue 1 Pg. 100-4 (Jan 2011) ISSN: 1536-3732 [Electronic] United States
PMID21187770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • CDK2AP2 protein, human
  • Oncogene Proteins
  • S100 Calcium Binding Protein A7
  • S100 Proteins
  • S100A7 protein, human
  • alpha-Defensins
  • human neutrophil peptide 1
  • human neutrophil peptide 3
  • Matrix Metalloproteinase 3
Topics
  • Biomarkers, Tumor (genetics)
  • Biopsy
  • Cell Transformation, Neoplastic
  • Down-Regulation
  • Fibroma (genetics)
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Gingival Neoplasms (genetics)
  • Humans
  • Immunoenzyme Techniques
  • Matrix Metalloproteinase 3 (genetics)
  • Oncogene Proteins (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • S100 Calcium Binding Protein A7
  • S100 Proteins (genetics)
  • alpha-Defensins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: